Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07573540 · ClinicalTrials.gov registry record · NA
Optimizing Smart Technology for Addiction Recovery
A NA study, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 416
- Enrollment target
NCT07573540: Recruiting NA study, sponsored by University of Wisconsin, Madison.
NCT07573540 is a NA study that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 416 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07573540, a NA study, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 416 participants
- Enrollment target
Study Summary
The goal of this study is to develop a machine-learning guided recovery messaging system. The main question it aims to answer is can messages be used to: * help people to improve their health * make changes in people's lives to address alcohol and substance use Participants will: * complete surveys * use a recovery-support digital therapeutic system
Primary Outcome
Measured as days of engagement with the recovery system.
Interventions
- DEVICE STAR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2025-09-24 |
| Est. Completion | 2029-07-31 |
| Phase | NA |
What NCT07573540 shows while recruiting
NCT07573540 is an interventional study that assigns participants to a tested intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which STAR is the first listed.
NCT07573540 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07573540 about?
NCT07573540 is a clinical study titled "Optimizing Smart Technology for Addiction Recovery". The goal of this study is to develop a machine-learning guided recovery messaging system. The main question it aims to answer is can messages be used to: * help people to improve their health * make changes in people's lives to address alcohol and substance use Participants will: * complete surve...
What is the current status of trial NCT07573540?
This trial is currently recruiting. It is a NA study. The enrollment target is 416 participants. The study started on 2025-09-24. Estimated completion is 2029-07-31.
What interventions are being tested in trial NCT07573540?
The interventions under investigation include: STAR (DEVICE).
Who is sponsoring clinical trial NCT07573540?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07573540's enrollment target sits among peer trials
416 241st of 2000 higher than 1,760 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI